Tamboli Ajim bought TRAX

April 21, 2026 · Form 4 insider transaction

Tamboli Ajim bought 41,233 shares of First Tracks Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
41,233
Price
$0.00
Total value
N/A
RoleOfficer
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateApril 21, 2026
Filing dateApril 23, 2026
Shares owned after41,233
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The stock option vests as to 25% of the total shares on April 20, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

View the original Form 4 on SEC EDGAR